HOME >> MEDICINE >> NEWS
Online calculator and chemotherapy order systems reduce medication errors in children

Two new studies from the Johns Hopkins Children's Center show that computerizing ordering of chemotherapy and other types of intravenous drug infusions for children greatly reduces the risk of potentially dangerous medical errors.

An online infusion calculator and a computerized drug ordering system, developed under the leadership of Christoph Lehmann, M.D., director of clinical information technology at the Children's Center, have been in use there for about three years, but this is the first time that researchers have measured their impact on medication errors.

Children in general are three times more likely than adults to be victims of medication errors because both ordering and dosing are more complex in children than adults, according to Lehmann. In children, dosing is based on calculations factoring in age, height and weight, and miscalculations and rounding errors could cause life-threatening harm. Dosing errors also cause more ill effects in children because still-developing bodies absorb, metabolize and excrete drugs at different rates than adults and thus have lower tolerance for medication overdose. Children undergoing treatment for cancer are at even greater risk because the general dangers of potent chemicals are compounded by the dosing challenges.

"Our findings reveal that using a Web-based calculator makes it less likely to order and give a child the wrong dose or commit other errors, such as omitting patient information, weight parameters or infusion rates," explains Lehmann, lead author of the Web-based calculator study, which appears in the May 8 issue of Pediatric Critical Care Medicine. "Our calculator stops ordering errors before they can even reach the pharmacy, let alone the patient."

The calculator computes all doses, advises and warns of drug interactions and automatically offers "default" doses and drug dilutions to help doctors avoid overdosing and under-dosing.

For the study, researchers compar
'"/>

Contact: Katerina Pesheva
epeshev1@jhmi.edu
410-516-4996
Johns Hopkins Medical Institutions
8-May-2006


Page: 1 2 3 4

Related medicine news :

1. Online education program better source of information for patients
2. Online book helps children understand the effects of stroke
3. Online ear and hearing diagnosis to break sound barrier
4. Online analytical toolbox for cancer and other biomedical research
5. Researchers show beneficial role of risk calculator in fighting progression of glaucoma
6. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
7. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
8. Brain-boosting pill alleviates post-chemotherapy fogginess
9. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
10. Most pediatric chemotherapy mistakes reach patients
11. Growth factors given with chemotherapy associated with increased risk of blood diseases

Post Your Comments:
(Date:8/22/2014)... News) -- The air in American cities is getting ... Thursday. Significant progress has been made in reducing ... decades, the agency said in a news release. ... reduction in mercury from human sources such as coal-fired ... 84 percent fall in lead, which harms brain development ...
(Date:8/22/2014)... leather seat covers provided by Lseat.comare meticulously in house ... needs. Recently, the company has unveiled its latest assortment of ... wants to provide worldwide clients with more high quality items. ... a long time. According to the company’s sales manager, all ... all the new products, Chevrolet Camaro leather seat covers ...
(Date:8/22/2014)... NY (PRWEB) August 22, 2014 ... Chinese orthopedic instrument industry, some foreign and domestic ... instrument market though mergers and acquisitions. In 2012, ... maker in China-- China Kanghui Holdings for USD ... China’s largest trauma product makers-- Trauson Holdings Company ...
(Date:8/22/2014)... The graft-versus-host disease (GVHD) treatment market value will ... by 2018, at a Compound Annual Growth Rate (CAGR) ... – Opportunity Analysis and Forecasts to 2018” states that ... (6MM: the US, France, Germany, Italy, Spain and the ... (5EU), where multiple product launches will accelerate the market ...
(Date:8/22/2014)... 2014 Tug McGraw Foundation and Team McGraw ... to participate in the 39th Annual Marine Corps Marathon on ... will join forces in coaching, training and participation for the ... our nation's capital and is often referred to as the ... Corps Marathon is the largest marathon in the world that ...
Breaking Medicine News(10 mins):Health News:Air in U.S. Cities Getting Cleaner, EPA Says 2Health News:Custom 1993-1996 Chevrolet Camaro Leather Seat Covers Now for Sale at Lseat.com 2Health News:China Orthopedic Instrument Industry 2014- Global Industry Size, Share, Trend, Growth and Forecast 2017 2Health News:Graft-Versus-Host Disease Treatment Market Worth $409.0m by 2018 Says a New Report Available at MarketOptimizer.org 2Health News:Graft-Versus-Host Disease Treatment Market Worth $409.0m by 2018 Says a New Report Available at MarketOptimizer.org 3Health News:Graft-Versus-Host Disease Treatment Market Worth $409.0m by 2018 Says a New Report Available at MarketOptimizer.org 4Health News:Tug McGraw Foundation and Team Red White and Blue Join to Run in Marine Corps Marathon 2Health News:Tug McGraw Foundation and Team Red White and Blue Join to Run in Marine Corps Marathon 3
(Date:8/21/2014)... BreedIT Corp., (OTCQB: BRDT) ... worldwide license holder and distributor of highly sophisticated ... today is pleased to announce the formation of ... a leading Israeli medical Cannabis breeder. ... breeds of medical Cannabis to meet the requests ...
(Date:8/21/2014)... Aug. 21, 2014  AliveCor, Inc. announced ... Administration (FDA) has granted the company clearance ... (AFib), the most common form of cardiac ... detects if patients are experiencing AFib through ... mobile phone based AliveCor® Heart Monitor, so ...
(Date:8/21/2014)... 2014   Royal Philips (NYSE: ... has received 510(k) clearance from the U.S. Food ... application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through ... with pre-procedural, high-precision positioning to treat aortic stenosis ... is available as part of Philips IntelliSpace ...
Breaking Medicine Technology:BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3
Cached News: